Samuel Wilkinson
Yale University
H-index: 32
North America-United States
Top articles of Samuel Wilkinson
The Rapidly Shifting Ketamine Landscape in the US
JAMA psychiatry
2024/1/3
The Neurobiology of Stress: Vulnerability, Resilience, and Major Depression: Ketamine and the neurobiology of depression: Toward next-generation rapid-acting antidepressant …
Proceedings of the National Academy of Sciences of the United States of America
2023/12/12
Ketamine and the neurobiology of depression: Toward next-generation rapid-acting antidepressant treatments
Proceedings of the National Academy of Sciences
2023/12/5
Cognitive behavioral therapy following esketamine for major depression and suicidal ideation for relapse prevention: the CBT-ENDURE randomized clinical trial study protocol
Psychiatry research
2023/12/1
Psychedelic renaissance: revitalized potential therapies for psychiatric disorders
2023/11/2
Efficacy and Safety of Esketamine Nasal Spray in Patients with Treatment-Resistant Depression Who Completed a Second Induction Period: Analysis of the Ongoing SUSTAIN-3 Study
CNS drugs
2023/8
Trends in illicit ketamine seizures in the US from 2017 to 2022
JAMA psychiatry
2023/7/1
Long-term safety and maintenance of response with esketamine nasal spray in participants with treatment-resistant depression: interim results of the SUSTAIN-3 study
Neuropsychopharmacology
2023/7
Ketamine versus ECT for nonpsychotic treatment-resistant major depression
New England Journal of Medicine
2023/6/22
The role of psychotherapy in the management of treatment-resistant depression
2023/6/1
Predictors of response and remission in patients with treatment-resistant depression: A post hoc pooled analysis of two acute trials of esketamine nasal spray
Psychiatry research
2023/5/1
Pharmacological and Somatic Treatment Effects on Suicide in Adults: A Systematic Review and Meta-Analysis
2023/4
Twenty-year trends in use of electroconvulsive therapy among homeless and domiciled veterans with mental illness
CNS spectrums
2023/4
Effects of electroconvulsive therapy on functional outcomes among medicare patients with comorbid depression and dementia: a nationwide 1-year follow-up study
The Journal of Clinical Psychiatry
2023/1/25
Efficacy and safety of ketamine vs electroconvulsive therapy among patients with major depressive episode: a systematic review and meta-analysis
2022/12/1
International pooled patient-level meta-analysis of ketamine infusion for depression: in search of clinical moderators
Molecular psychiatry
2022/12
A participant-level integrative data analysis of differential placebo response for suicidal ideation and nonsuicidal depressive symptoms in clinical trials of intravenous …
International Journal of Neuropsychopharmacology
2022/10/1
Ketamine in the Real World: Where Do We Go From Here?
The Journal of Clinical Psychiatry
2022/9/14
At-home ketamine; still a lot to learn.
Journal of Affective Disorders
2022/9/3
Evaluation of the trajectory of depression severity with ketamine and esketamine treatment in a clinical setting
JAMA psychiatry
2022/7/1
